Pablo Andres Olivera (Pablo A Olivera, P Olivera, Pablo Olivera)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Peritoneal Dialysis

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Journal of the Canadian Association of Gastroenterology

The Journal of rheumatology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pablo Andres Olivera, Juan S Lasa, Giovanni Peretto, Stephane Zuily, Silvio Danese, Laurent Peyrin Biroulet
Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs. Alimentary pharmacology & therapeutics (2023)
Pablo Andres Olivera, Mark S Silverberg
Biomarkers That Predict Crohn's Disease Outcomes. Journal of the Canadian Association of Gastroenterology 7 (1) (2023)
Pablo Andres Olivera, Mark S Silverberg
Biomarkers That Predict Crohn's Disease Outcomes. Journal of the Canadian Association of Gastroenterology 7 (1) (2023)
Juan Sebastian Lasa, Ezequiel Nazario, Gonzalo De Sanctis, María Fernández Recalde, Juan Pereira Redondo, Juan Montañana, Fernando Spernanzoni, Ignacio Zubiaurre, Pablo Andres Olivera
Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control Study. Inflammatory bowel diseases (2023)
Ferdinando D'Amico, Virginia Solitano, Fernando Magro, Pablo Andres Olivera, Jonas Halfvarson, David T Rubin, Axel Dignass, Sameer Al Awadhi, Taku Kobayashi, Natália Souza Freitas Queiroz, Marta Calvo, Paulo Gustavo Kotze, Subrata Ghosh, Laurent Peyrin-Biroulet, Silvio Danese
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus. Journal of clinical medicine 12 (19) (2023)
Robert D Inman, Michael Tang, Pablo Andres Olivera, Robert Davies Inman
Differential Effects of Integrin Blockade on Gut and Sacroiliac Joint Inflammation. The Journal of rheumatology (2023)
Juan Sebastian Lasa, Ignacio Zubiaurre, Astrid Rausch, Pablo Andres Olivera
PLACEBO USE IN THE CONTEXT OF INFLAMMATORY BOWEL DISEASE CLINICAL TRIALS. Arquivos de gastroenterologia 57 (1) (2020)
Pablo Andres Olivera, W J Sandborn, J Panés, C Baumann, G D'Haens, S Vermeire, Silvio Danese, Laurent Peyrin Biroulet
Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey. Alimentary pharmacology & therapeutics 47 (6) (2018)